Which of the following anti-hypertensive drug can safely administer in breast feeding/Lactating mother?

NORCET 3 - 2022 (Shift-1)

Pharmacology

Hard

Appeared in: NORCET 3 - 2022 (Shift-1)

Explanation

Enalapril is an Angiotensin-Converting Enzyme (ACE) inhibitor.
It is considered one of the preferred ACE inhibitors for use during breastfeeding.
The amount of enalapril that passes into breast milk is very low, resulting in sub-clinical, negligible levels in the infant's bloodstream.
This minimal exposure poses a very low risk of adverse effects to the nursing infant.

Option A: Lisinopril is also an ACE inhibitor, but there is less published data on its excretion into breast milk compared to enalapril. Due to the limited information, it is used with more caution and is not the first choice when a safer alternative like enalapril is available.
Option C: Losartan is an Angiotensin II Receptor Blocker (ARB). ARBs are generally not recommended during breastfeeding due to a lack of safety data and a theoretical concern for adverse effects on the infant's developing renal system, similar to the risks seen with in-utero exposure.
Option D: Hydrochlorothiazide is a thiazide diuretic. While it is sometimes used, it has the potential to decrease milk production and suppress lactation, particularly at higher doses. This can interfere with breastfeeding, making it a less desirable option.

Visual 1: Table - A comparative table showing different classes of antihypertensive drugs (ACE inhibitors, ARBs, Beta-blockers, Calcium channel blockers, Diuretics) and their respective safety ratings (e.g., L1-L5) for use during lactation. This would provide a quick reference for students.
Visual 2: Infographic - An infographic illustrating the key considerations for prescribing medication to a lactating mother, including factors like the drug's molecular weight, protein binding, lipid solubility, and the infant's age.

Clinical Relevance

Nursing practice connection: Knowing Pharmacology and medication safety during lactation helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
When caring for a postpartum patient with hypertension, the nurse must prioritize both maternal blood pressure control and the safety of the breastfeeding infant.
Nursing interventions include monitoring the mother's blood pressure and the infant for any potential side effects, such as lethargy, poor feeding, or changes in urine output.
Patient education is crucial. The nurse should advise the mother to take the medication immediately after breastfeeding to minimize the drug concentration in the milk at the next feeding.

How to Approach the Question

First, identify the specific patient population in the question: a breastfeeding/lactating mother. This is the critical context.
Next, analyze the drug classes of the given options: Lisinopril and Enalapril (ACE inhibitors), Losartan (ARB), and Hydrochlorothiazide (diuretic).
Recall or look up the general safety principles for these drug classes during lactation.
Eliminate options that are generally contraindicated or have significant undesirable effects. ARBs (Losartan) are typically avoided due to potential infant toxicity. Diuretics (Hydrochlorothiazide) are used cautiously as they can reduce milk supply.
Compare the remaining options. Both Lisinopril and Enalapril are ACE inhibitors. The choice between them depends on which has a better-established safety profile (more data, lower milk excretion).
Select Enalapril as it is widely recognized to have very low transfer into breast milk, making it the safest choice among the given options.

Concept Tested & Keywords

Concept Tested: Pharmacology and medication safety during lactation.
Stem keywords: anti-hypertensive drug, safely administer, breast feeding, Lactating mother
Lead-in keywords: Which

QMVNWgtURwmr8zpUdxllP